Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Finding China: Four Urban areas for a Remarkable Excursion - 2Don't miss the waxing moon swing by the Beehive star cluster March 27
- 34 Excellent Remote Headphones of 2024
- 4World's oldest known tortoise still very much alive despite rumor to the contrary
- 515 skywatching events you won't want to miss in 2026
- Opening Innovativeness: Moving Thoughts and Tasks
- Congo declares its latest Ebola outbreak over, after 43 deaths
- Embrace Effortlessness: Moderation and Cleaning up Tips
- Minute Maid’s frozen juice concentrate is ending after 80 years — and so is a certain kind of kitchen ritual
- Worldwide Objections Ideal For A Golf Outing
- Dramatic Dominance d: A Survey of \Feelings in front of an audience\ Theater Play
- Malaysia To Revive Search for Missing Flight MH370
- Hyundai Is Keeping the i30 Alive While America Keeps Losing Cars Like It
- Criminal Guard Lawyer Expenses: What Would it be advisable for you to Hope to Pay?
